Brief: Pardes Biosciences And FS Development Corp. II Announce Merger Agreement

Pardes Biosciences

29/06/2021 11:06

June 29 (Reuters) - FS Development II Corp  FSII.O :
    * PARDES BIOSCIENCES AND FS DEVELOPMENT CORP. II ANNOUNCE
MERGER
AGREEMENT CREATING PUBLICLY LISTED BIOPHARMACEUTICAL COMPANY
ADVANCING ORAL ANTIVIRAL DRUGS TO TREAT AND PREVENT SARS-COV-2
INFECTIONS
    * FS DEVELOPMENT II CORP - TOTAL PROCEEDS FROM TRANSACTION
EXPECTED TO BE APPROXIMATELY $276 MILLION
    * FS DEVELOPMENT II CORP - COMBINED COMPANY IS EXPECTED TO
BE
LISTED ON NASDAQ UNDER TICKER SYMBOL PRDS
    * FS DEVELOPMENT II CORP -  A GROUP OF INVESTORS COMMITTED
TO
PARTICIPATE IN TRANSACTION THROUGH A COMMON STOCK PIPE OF ABOUT
$75 MILLION AT $10/SHARE

Source text for Eikon:  ID:nBw3XhWL2a 
Further company coverage:  FSII.O 

 ((Reuters.Briefs@thomsonreuters.com;))